{
    "title": "113_hr1024",
    "content": "The \"Medication Therapy Management Empowerment Act of 2013\" allows access to services under medication therapy management programs for Medicare Part D eligible individuals with single chronic diseases. The \"Medication Therapy Management Empowerment Act of 2013\" expands access to medication therapy management programs for Medicare Part D eligible individuals with multiple chronic diseases or single chronic diseases like diabetes, hypertension, heart failure, and respiratory diseases. The \"Medication Therapy Management Empowerment Act of 2013\" broadens access to medication therapy management programs for Medicare Part D eligible individuals with single chronic diseases such as asthma, bone disease-arthritis, rheumatoid arthritis, or mental health disorders. The \"Medication Therapy Management Empowerment Act of 2013\" expands access to medication therapy management programs for Medicare Part D eligible individuals with specific chronic diseases, subject to cost projections by the Centers for Medicare & Medicaid Services. The Chief Actuary for the Centers for Medicare & Medicaid Services will review the impact of applying a clause to a chronic disease on Medicare program costs within five years of determination. The Secretary will review the Chief Actuary's findings to determine if applying a clause to a single chronic disease increases costs to the Federal government under the Medicare program. If costs do not increase, the clause may continue to be applied. The Secretary will review the Chief Actuary's findings to determine the impact of applying a clause to a single chronic disease on health outcomes and costs to the Federal government under the Medicare program."
}